oxybutynin and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

oxybutynin has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ma, Y; Sui, D; Wang, L; Wang, Y; Xu, H; Yu, X; Zhang, P	1

Other Studies

1 other study(ies) available for oxybutynin and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Article	Year
Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson's disease. Journal of pharmacological sciences, 2018, Volume: 138, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Cutaneous; Animals; Apoptosis; Corpus Striatum; Delayed-Action Preparations; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Male; Mice, Inbred C57BL; Mitochondria; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Pramipexole; Superoxide Dismutase; Transdermal Patch	2018

Article

Year

Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson's disease.

Journal of pharmacological sciences, 2018, Volume: 138, Issue:1

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Cutaneous; Animals; Apoptosis; Corpus Striatum; Delayed-Action Preparations; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Male; Mice, Inbred C57BL; Mitochondria; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Pramipexole; Superoxide Dismutase; Transdermal Patch

2018